In This Article:
Over the last 7 days, the market has dropped 2.0%. In contrast to the last week, the market is up 5.0% over the past year, with earnings forecast to grow by 14% annually. In this context, identifying growth companies with high insider ownership can be crucial as it often signals confidence in long-term prospects and alignment of interests between management and shareholders.
Top 10 Growth Companies With High Insider Ownership In The United Kingdom
| Name | Insider Ownership | Earnings Growth |
| Filtronic (AIM:FTC) | 28.6% | 33.5% |
| Plant Health Care (AIM:PHC) | 34.7% | 121.3% |
| Gulf Keystone Petroleum (LSE:GKP) | 12.1% | 74.6% |
| Integrated Diagnostics Holdings (LSE:IDHC) | 26.7% | 23.5% |
| Foresight Group Holdings (LSE:FSG) | 31.9% | 27.9% |
| Helios Underwriting (AIM:HUW) | 23.9% | 14.7% |
| Belluscura (AIM:BELL) | 39.5% | 117.8% |
| Velocity Composites (AIM:VEL) | 27.6% | 173.3% |
| B90 Holdings (AIM:B90) | 24.4% | 142.7% |
| Hochschild Mining (LSE:HOC) | 38.4% | 53.8% |
Here's a peek at a few of the choices from the screener.
Craneware
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Craneware plc, with a market cap of £821.41 million, develops, licenses, and supports computer software for the healthcare industry in the United States.
Operations: Revenue from healthcare software amounts to $180.56 million.
Insider Ownership: 17%
Craneware, a growth company with high insider ownership, is forecasted to achieve significant annual earnings growth of 29.39% over the next three years, outpacing the UK market's 13.5%. Despite a lower projected Return on Equity of 11.2%, Craneware's revenue is expected to grow at 6.7% annually, faster than the market average. Recent strategic collaborations with Microsoft enhance its innovation capabilities and market reach through Azure Marketplace integrations and AI advancements in healthcare solutions.
-
Navigate through the intricacies of Craneware with our comprehensive analyst estimates report here.
-
Our expertly prepared valuation report Craneware implies its share price may be too high.
Judges Scientific
Simply Wall St Growth Rating: ★★★★★☆
Overview: Judges Scientific plc designs, manufactures, and sells scientific instruments with a market cap of £664.13 million.
Operations: The company generates revenue from two main segments: Vacuum (£63.60 million) and Materials Sciences (£72.50 million).
Insider Ownership: 11.9%
Judges Scientific, characterized by high insider ownership, is projected to achieve significant annual earnings growth of 26.22% over the next three years, surpassing the UK market's 13.5%. Despite a recent decline in profit margins from 11% to 7%, analysts agree that its stock price will rise by 20.1%. Recent changes in company bylaws and a final dividend increase to £0.68 per share were approved at the May AGM, reflecting strong governance and shareholder returns.